gms | German Medical Science

10. Kongress für Infektionskrankheiten und Tropenmedizin (KIT 2010)

Deutsche Gesellschaft für Infektiologie,
Deutsche AIDS-Gesellschaft,
Deutsche Gesellschaft für Tropenmedizin und Internationale Gesundheit,
Paul-Ehrlich-Gesellschaft für Chemotherapie

23.06. - 26.06.2010, Köln

Antimicrobial resistance for neisseria gonorrhoeae in patients at a private doctor's office over a period of 24 month

Antibiotikaresistenzen von Gonokokken bei Patienten einer infektiologischen Schwerpunktpraxis in den Jahren 2008/2009

Meeting Abstract

  • G. Knecht - Infektiologikum Frankfurt, Germany
  • A. Bodtlaender - Infektiologikum Frankfurt, Germany
  • L. Locher - Infektiologikum Frankfurt, Germany
  • T. Lutz - Infektiologikum Frankfurt, Germany
  • P. Gute - Infektiologikum Frankfurt, Germany
  • U. Schoenian - Infektiologikum Frankfurt, Germany

10. Kongress für Infektionskrankheiten und Tropenmedizin (KIT 2010). Köln, 23.-26.06.2010. Düsseldorf: German Medical Science GMS Publishing House; 2010. DocP24

doi: 10.3205/10kit080, urn:nbn:de:0183-10kit0803

Published: June 2, 2010

© 2010 Knecht et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.



Objectives: Over the past years Neisseria gonorrhoeae has acquired clinical significant resistance to sulfonamides, tetracyclines, penicillins and ciprofloxacin.

Methods: To determine German trends in the prevalence of microbial resistance of.N. gonorrhoeae we performed medical examinations with genital smears in sixty-three male patients with clinical urethritis in the period from 1/2008 to 12/2009.

All included patient were men having sex with men (MSM) and seventynine percent of them were HIV positive. We also looked for other sexual transmitted diseases.

We treated all patients with 1g azithromycin once und change it if necesarry after we had the resistenttests.

Results: We found 64% ciprofloxacin-resistance, 22% doxycyclin-resistance, 8% azithromycin-resistance, 5% ceftriaxon-resistance and 7% cefixim-resistance.

Conclusions: Ongoing nationwide and local antimicrobial susceptibility monitoring is crucial to ensure appropriate treatment of gonorrhoeae.